Houck Constance S, Khodorova Alla, Reale Amy M, Strichartz Gary R, Davar Gudarz
Department of Anesthesiology, Perioperative and Pain Medicine, Children's Hospital, Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA Pain Research Center, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
Pain. 2004 Aug;110(3):719-726. doi: 10.1016/j.pain.2004.05.012.
Endothelin-1 (ET-1) applied to the sciatic nerve or injected into the plantar hindpaw of rats induces pain behavior (ipsilateral hindpaw flinching) and selective excitation of nociceptors by activation of endothelin-A (ET(A)) receptors. To determine the pharmacological profile of the sensory fibers that mediate this pain behavior, we administered lidocaine (LID, a non-selective conduction blocker) or tetrodotoxin (TTX) prior to ET-1. LID (1 or 2%, 0.1 ml) was injected percutaneously into the sciatic notch, or TTX (10 microM, 4 microl) was injected into the sciatic nerve prior to the more distal application of ET-1 (400 microM, 40 microl) onto the sciatic nerve or subcutaneously into the plantar hindpaw (400 microM, 10 microl). LID inhibited ET-1-induced flinching in a dose-dependent manner; the mean total number of flinches was reduced by 39% for 1% LID and by 87% for 2% LID. In contrast, TTX failed to inhibit flinching behavior induced by sciatic nerve application of ET-1 despite a similar magnitude of motor and sensory blockade as that observed with 2% LID. Partial blockade of flinching behavior by intraneural TTX (mean total flinches were reduced by 51%) was observed after subcutaneous injection of ET-1. Unexpectedly, ET-1 prolonged the actions of 1% LID and, even when applied alone, produced clear signs of motor and sensory conduction block. These results are evidence that ET-1-induced pain is transmitted to the central nervous system via sensory fibers using tetrodotoxin-resistant sodium channels, and that ET-1 has analgesic actions that exist despite the activation of local pain pathways.
将内皮素 -1(ET -1)应用于大鼠坐骨神经或注射到大鼠后足底,可通过激活内皮素 A(ET(A))受体诱导疼痛行为(同侧后爪退缩)并选择性地兴奋伤害感受器。为了确定介导这种疼痛行为的感觉纤维的药理学特征,我们在给予 ET -1 之前给予利多卡因(LID,一种非选择性传导阻滞剂)或河豚毒素(TTX)。在将 ET -1(400 μM,40 μl)更向远端应用于坐骨神经或皮下注射到后足底(400 μM,10 μl)之前,将 LID(1% 或 2%,0.1 ml)经皮注射到坐骨切迹,或将 TTX(10 μM,4 μl)注射到坐骨神经中。LID 以剂量依赖性方式抑制 ET -1 诱导的退缩;1% LID 使退缩的平均总数减少 39%,2% LID 使退缩的平均总数减少 87%。相比之下,尽管 TTX 产生的运动和感觉阻滞程度与 2% LID 相似,但 TTX 未能抑制坐骨神经应用 ET -1 诱导的退缩行为。皮下注射 ET -1 后,观察到神经内注射 TTX 对退缩行为有部分阻滞作用(退缩的平均总数减少 51%)。出乎意料的是,ET -1 延长了 1% LID 的作用,并且即使单独应用,也会产生明显的运动和感觉传导阻滞迹象。这些结果证明,ET -1 诱导的疼痛是通过使用河豚毒素抗性钠通道的感觉纤维传递到中枢神经系统的,并且尽管局部疼痛通路被激活,但 ET -1 仍具有镇痛作用。